These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 5082465

  • 21. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD, Scaduto P, Galluzzo A, Donatelli M, Morici ML, Mangano MT, Messina L.
    Minerva Cardioangiol; 1976 May; 24(5):352-9. PubMed ID: 1012481
    [No Abstract] [Full Text] [Related]

  • 22. Role of renin classification for diuretic treatment of black hypertensive patients.
    Holland OB, Gomez-Sanchez C, Fairchild C, Kaplan NM.
    Arch Intern Med; 1979 Dec; 139(12):1365-70. PubMed ID: 518220
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H, Lübke H, Klaus D, Zehner J, Witzgall H.
    Dtsch Med Wochenschr; 1978 Oct 20; 103(42):1650-5. PubMed ID: 699788
    [Abstract] [Full Text] [Related]

  • 24. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec 20; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 25. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM, Suthers MB, Friedman A, Johnston CI.
    Med J Aust; 1978 May 06; 1(9):509-12. PubMed ID: 353458
    [Abstract] [Full Text] [Related]

  • 26. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M, Kirsten R, Bückert C.
    Pharmatherapeutica; 1984 May 06; 3(9):595-606. PubMed ID: 6374680
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension.
    Alhenc-Gelas F, Plouin PF, Ducrocq MB, Corvol P, Menard J.
    Am J Med; 1978 Jun 06; 64(6):1005-12. PubMed ID: 655186
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A, Feely J.
    Am J Hypertens; 2005 Jan 06; 18(1):50-5. PubMed ID: 15691617
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A, Bagdonas G, Yankauskene L, Kazanavichus G.
    Ter Arkh; 2006 Jan 06; 78(2):61-4. PubMed ID: 16613101
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The effect of spironolactone and trichlormethiazide on blood pressure, plasma dry weight and plasma potassium in the elderly hypertension].
    Nakada I, Sekimoto H, Nakano T, Shimada O, Horibe N, Fuse N.
    Nihon Ronen Igakkai Zasshi; 1983 Nov 06; 20(6):491-9. PubMed ID: 6371331
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.